We are live on
!
Find out more
RC
Roundview Capital Portfolio holdings
AUM
$1.61B
1-Year Est. Return
16.92%
This Fund
S&P 500
This Quarter
Est. Return
+3.25%
1 Year Est. Return
+16.92%
3 Year Est. Return
+63.17%
5 Year Est. Return
+78.22%
10 Year Est. Return
+279.65%
AUM
$343M
AUM Growth
+$20.7M
(+6.4%)
Cap. Flow
+$11.8M
Cap. Flow
% of AUM
3.44%
Top 10 Holdings %
Top 10 Hldgs %
25.31%
Holding
228
New
31
Increased
97
Reduced
42
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$1.21M |
| 2 |
GE Aerospace
GE
|
+$977K |
| 3 |
McDonald's
MCD
|
+$962K |
| 4 |
Oracle
ORCL
|
+$809K |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$712K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
The Mosaic Company
MOS
|
+$1.51M |
| 2 |
AbbVie
ABBV
|
+$1.5M |
| 3 |
Cencora
COR
|
+$1.22M |
| 4 |
T. Rowe Price
TROW
|
+$1.17M |
| 5 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$1.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.61% |
| 2 | Healthcare | 10.08% |
| 3 | Technology | 8.36% |
| 4 | Industrials | 8.1% |
| 5 | Communication Services | 7.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
New York Times
NYT
$11.6B
| $460K | 0.13% |
26,000
+10,000
| +63% | +$164K |
|
152
Union Pacific
UNP
$182B
| $457K | 0.13% |
4,196
| – | – |
|
153
O'Reilly Automotive
ORLY
$72.4B
| $451K | 0.13% |
+30,900
| New | +$505K |
|
154
Schwab U.S Small- Cap ETF
SCHA
$22.5B
| $443K | 0.13% |
27,732
+2,816
| +11% | +$44.5K |
|
155
Cisco
CSCO
$450B
| $440K | 0.13% |
14,072
+2,010
| +17% | +$65.5K |
|
156
iShares MSCI South Korea ETF
EWY
$21.7B
| $426K | 0.12% |
6,288
| – | – |
|
157
Regeneron Pharmaceuticals
REGN
$68.8B
| $418K | 0.12% |
+852
| New | +$373K |
|
|
BWG
158
BrandywineGLOBAL Global Income Opportunities Fund
BWG
$129M
| $412K | 0.12% |
31,135
| – | – |
|
159
Texas Instruments
TXN
$255B
| $412K | 0.12% |
5,361
+1,150
| +27% | +$92.2K |
|
160
iShares Currency Hedged MSCI Eurozone ETF
HEZU
$565M
| $409K | 0.12% |
13,940
| – | – |
|
161
Qualcomm
QCOM
$176B
| $406K | 0.12% |
7,361
-1,200
| -14% | -$67K |
|
162
McKesson
MCK
$98.5B
| $401K | 0.12% |
+2,440
| New | +$370K |
|
163
iShares Russell Mid-Cap ETF
IWR
$56.8B
| $395K | 0.12% |
+8,220
| New | +$390K |
|
164
Abbott
ABT
$180B
| $391K | 0.11% |
8,045
+1,850
| +30% | +$83.7K |
|
165
Fresenius Medical Care
FMS
$13.2B
| $391K | 0.11% |
+8,092
| New | +$373K |
|
166
Keurig Dr Pepper
KDP
$40.4B
| $390K | 0.11% |
4,285
| – | – |
|
167
Nuveen Municipal Value Fund
NUV
$1.91B
| $390K | 0.11% |
39,176
| – | – |
|
168
SiriusXM
SIRI
$10B
| $383K | 0.11% |
+7,003
| New | +$358K |
|
169
Intel
INTC
$464B
| $371K | 0.11% |
11,006
+1,398
| +15% | +$50K |
|
170
United Therapeutics
UTHR
$26.3B
| $357K | 0.1% |
2,750
+200
| +8% | +$24.9K |
|
171
DaVita
DVA
$15.1B
| $356K | 0.1% |
5,503
| – | – |
|
172
Biogen
BIIB
$29.9B
| $353K | 0.1% |
+1,301
| New | +$344K |
|
173
Liberty Media Series A
FWONA
$22.3B
| $343K | 0.1% |
10,220
+193
| +2% | +$6.08K |
|
174
VanEck Morningstar Wide Moat ETF
MOAT
$11.5B
| $342K | 0.1% |
8,655
+500
| +6% | +$19.2K |
|
175
Altria Group
MO
$122B
| $338K | 0.1% |
4,545
+540
| +13% | +$39.5K |
|
Similar funds
FWP
GCP
ACB
SCM
SCI
PPW
BW
Roundview Capital's Q2 2017 Portfolio in Review
As of Q2 2017, Roundview Capital held 228 positions worth $343M, up 6.4% from $322M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Roundview Capital deployed $11.8M of net new capital in Q2 2017, opening 31 new positions and adding to 97 existing holdings. Its largest new stake was Novo Nordisk: 59,936 shares worth $1.28M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was AbbVie, an estimated $1.5M trimmed.
- Roundview Capital's largest Q2 2017 buy was Novo Nordisk: 59,936 shares worth $1.28M.
- Roundview Capital added most to GE Aerospace in Q2 2017, an estimated $977K increase.
- Roundview Capital's biggest Q2 2017 reduction was AbbVie, cutting an estimated $1.5M.
- Roundview Capital fully exited The Mosaic Company in Q2 2017, selling an estimated $1.51M.
- Roundview Capital's ten largest holdings make up 25% of its $343M portfolio in Q2 2017.
- Roundview Capital opened 31 new positions and closed 13 in Q2 2017.
- Roundview Capital's portfolio value rose 6.4% quarter-over-quarter to $343M.
Based on Roundview Capital's 13F filing for Q2 2017, filed 11 Aug 2017.